The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus

Ann Intern Med. 2003 Apr 1;138(7):587-92. doi: 10.7326/0003-4819-138-7-200304010-00017.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Benzothiadiazines
  • Blood Pressure
  • Calcium Channel Blockers / therapeutic use
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Angiopathies / drug therapy*
  • Diuretics
  • Evidence-Based Medicine
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / etiology
  • Sodium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzothiadiazines
  • Calcium Channel Blockers
  • Diuretics
  • Sodium Chloride Symporter Inhibitors